Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.
- SIGNA Sports United N.V. (NYSE: SSU) shares jumped 41.6% to $1.23.
- Canopy Growth Corporation (NASDAQ: CGC) gained 23% to $0.6660.
- Cibus, Inc. (NASDAQ: CBUS) rose 18.4% to $17.66.
- Cabaletta Bio, Inc. (NASDAQ: CABA) gained 15.7% to $15.42. Citigroup initiated coverage on Cabaletta Bio with a Buy rating and announced a price target of $22.
- Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) rose 15.5% to $12.26. Olema Pharmaceuticals announced a private placement of approximately $130 million.
- Insmed Incorporated (NASDAQ: INSM) surged 15% to $26.06 after the company released topline results from its Phase 3 ARISE study of ARIKAYCE for nontuberculous mycobacterial lung infection caused by Mycobacterium avium complex who had not started antibiotics.
- SNDL Inc. (NASDAQ: SNDL) gained 12.7% to $1.9848.
- Getty Images Holdings, Inc. (NYSE: GETY) gained 12.7% to $4.96.
- Brady Corporation (NYSE: BRC) rose 12.6% to $57.24 following better-than-expected quarterly results.
- Zai Lab Limited (NASDAQ: ZLAB) surged 11.8% to $29.20.
- Tilray Brands, Inc. (NASDAQ: TLRY) gained 11.8% to $3.3450. Roth MKM reiterated Tilray Brands with a Neutral and maintained a $2.5 price target.
- Aurora Innovation, Inc. (NASDAQ: AUR) rose 11.3% to $3.56.
- fuboTV Inc. (NYSE: FUBO) climbed 8.4% to $2.8729.
- Hannon Armstrong Sustainable Infrastructure Capital, Inc. (NASDAQ: HASI) gained 7.9% to $24.90.
- Digital World Acquisition Corp. (NASDAQ: DWAC) gained 7.8% to $17.80.
- Airbnb, Inc. (NASDAQ: ABNB) climbed 7.6% to $142.86 after it was announced the company will join the S&P 500.
- TROOPS, Inc. (NASDAQ: TROO) gained 7.3% to $4.1399.
- Vertex Energy, Inc. (NASDAQ: VTNR) jumped 5.8% to $4.7195.
- NextGen Healthcare, Inc. (NASDAQ: NXGN) shares gained 5.1% to $20.31. Thoma Bravo is in advanced talks to acquire NextGen Healthcare, Bloomberg reported.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.